Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage.

Tytuł:
Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage.
Autorzy:
Le Boiteux E; CNRS, Inserm, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.
Court F; CNRS, Inserm, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.
Guichet PO; INSERM-U1084, Poitiers, France.; Poitiers University, France.; Department of Cancer Biology, Poitiers Hospital, France.
Vaurs-Barrière C; CNRS, Inserm, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.
Vaillant I; CNRS, Inserm, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.
Chautard E; Pathology Department, Jean Perrin Center, Clermont-Ferrand, France.; INSERM, U1240 IMoST, Université Clermont Auvergne, Clermont-Ferrand, France.
Verrelle P; CIMB, INSERM U1196 CNRS UMR9187, Curie Institute, Orsay, France.; Radiotherapy Department, Curie Institute, Paris, France.; Université Clermont Auvergne, Clermont-Ferrand, France.
Costa BM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Karayan-Tapon L; INSERM-U1084, Poitiers, France.; Poitiers University, France.; Department of Cancer Biology, Poitiers Hospital, France.
Fogli A; CNRS, Inserm, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.; Biochemistry and Molecular Biology Department, Clermont-Ferrand Hospital, France.
Arnaud P; CNRS, Inserm, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.
Źródło:
Molecular oncology [Mol Oncol] 2021 Aug; Vol. 15 (8), pp. 1995-2010. Date of Electronic Publication: 2021 May 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: 2017- : Hoboken, New Jersey : John Wiley & Sons, Inc.
Original Publication: Amsterdam : Elsevier
MeSH Terms:
DNA Methylation*
Genes, Homeobox*
Promoter Regions, Genetic*
Brain Neoplasms/*genetics
Glioma/*genetics
Histones/*genetics
Brain Neoplasms/enzymology ; Brain Neoplasms/pathology ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Glioma/enzymology ; Glioma/pathology ; Humans ; Isocitrate Dehydrogenase/genetics ; Transcription, Genetic
References:
Mol Oncol. 2018 Jun;12(6):814-829. (PMID: 29575763)
Genome Res. 2012 Jun;22(6):1128-38. (PMID: 22466170)
Genome Biol. 2015 Jan 27;16:16. (PMID: 25622821)
Nat Commun. 2019 Apr 11;10(1):1679. (PMID: 30976011)
Sci Rep. 2015 Oct 08;5:14983. (PMID: 26447334)
J Pathol. 2006 May;209(1):15-24. (PMID: 16463268)
Oncotarget. 2017 Jan 17;8(3):4110-4124. (PMID: 27926531)
Nucleic Acids Res. 2012 Aug;40(15):e114. (PMID: 22718975)
Stem Cells Int. 2018 Jul 22;2018:3569493. (PMID: 30154863)
Genome Res. 2019 Oct;29(10):1605-1621. (PMID: 31533980)
Nature. 2012 Aug 23;488(7412):522-6. (PMID: 22854781)
J Mol Med (Berl). 2014 Aug;92(8):811-23. (PMID: 24996520)
Int J Cancer. 1992 Jul 30;51(6):892-7. (PMID: 1379214)
Int J Dev Biol. 2018;62(11-12):865-876. (PMID: 30604856)
Nucleic Acids Res. 2016 Jan 29;44(2):621-35. (PMID: 26400168)
J Clin Oncol. 2008 Jun 20;26(18):3015-24. (PMID: 18565887)
Curr Top Dev Biol. 2013;104:113-48. (PMID: 23587240)
Cancer Res. 2013 Jan 1;73(1):417-27. (PMID: 23108137)
Eur J Cancer. 2003 Jan;39(2):257-64. (PMID: 12509959)
Acta Neuropathol. 2007 Aug;114(2):97-109. (PMID: 17618441)
Int J Dev Biol. 2018;62(11-12):807-818. (PMID: 30604850)
Oncogene. 2003 Sep 25;22(41):6462-8. (PMID: 14508527)
Cancer Discov. 2012 May;2(5):401-4. (PMID: 22588877)
Curr Neurol Neurosci Rep. 2013 May;13(5):345. (PMID: 23532369)
Cell. 2016 Jan 28;164(3):550-63. (PMID: 26824661)
Cell Mol Life Sci. 2020 Oct;77(19):3797-3821. (PMID: 32239260)
Genes Dev. 2018 Apr 1;32(7-8):512-523. (PMID: 29632085)
Int J Cancer. 2011 Feb 15;128(4):826-38. (PMID: 20473906)
Genome Biol. 2013 Mar 25;14(3):R25. (PMID: 23531360)
J Pathol. 2018 Oct;246(2):205-216. (PMID: 30009411)
Cancers (Basel). 2019 Apr 10;11(4):. (PMID: 30974862)
Sci Signal. 2013 Apr 02;6(269):pl1. (PMID: 23550210)
Epigenetics. 2009 May 16;4(4):255-64. (PMID: 19550145)
Science. 2003 Jul 18;301(5631):331-3. (PMID: 12869751)
Acta Neuropathol. 2016 Jun;131(6):803-20. (PMID: 27157931)
Int J Mol Sci. 2012;13(6):6983-94. (PMID: 22837675)
Cancer Res. 2010 Jan 15;70(2):453-62. (PMID: 20068170)
Cancer Cell. 2013 Jan 14;23(1):9-22. (PMID: 23245995)
Mol Cancer. 2011 May 22;10:60. (PMID: 21600039)
Genes Dev. 2015 Jun 15;29(12):1203-17. (PMID: 26109046)
Contributed Indexing:
Keywords: HOX genes; alternative promoters; cancer; epigenetics; glioma; glioma stem cells
Substance Nomenclature:
0 (Histones)
EC 1.1.1.41 (Isocitrate Dehydrogenase)
Entry Date(s):
Date Created: 20210315 Date Completed: 20220328 Latest Revision: 20220328
Update Code:
20240104
PubMed Central ID:
PMC8334257
DOI:
10.1002/1878-0261.12944
PMID:
33720519
Czasopismo naukowe
In human, the 39 coding HOX genes and 18 referenced noncoding antisense transcripts are arranged in four genomic clusters named HOXA, B, C, and D. This highly conserved family belongs to the homeobox class of genes that encode transcription factors required for normal development. Therefore, HOX gene deregulation might contribute to the development of many cancer types. Here, we study HOX gene deregulation in adult glioma, a common type of primary brain tumor. We performed extensive molecular analysis of tumor samples, classified according to their isocitrate dehydrogenase (IDH1) gene mutation status, and of glioma stem cells. We found widespread expression of sense and antisense HOX transcripts only in aggressive (IDHwt) glioma samples, although the four HOX clusters displayed DNA hypermethylation. Integrative analysis of expression, DNA methylation, and histone modification signatures along the clusters revealed that HOX gene upregulation relies on canonical and alternative bivalent CpG island promoters that escape hypermethylation. H3K27me3 loss at these promoters emerges as the main cause of widespread HOX gene upregulation in IDHwt glioma cell lines and tumors. Our study provides the first comprehensive description of the epigenetic changes at HOX clusters and their contribution to the transcriptional changes observed in adult glioma. It also identified putative 'master' HOX proteins that might contribute to the tumorigenic potential of glioma stem cells.
(© 2021 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies